English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  An action plan for pan-European defence against new SARS-CoV-2 variants

Priesemann, V., Balling, R., Brinkmann, M. M., Ciesek, S., Czypionka, T., Eckerle, I., et al. (2021). An action plan for pan-European defence against new SARS-CoV-2 variants. The Lancet, 397, 469-470. doi:10.1016/S0140-6736(21)00150-1.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Priesemann, Viola1, Author           
Balling, Rudi, Author
Brinkmann, Melanie M, Author
Ciesek, Sandra, Author
Czypionka, Thomas, Author
Eckerle, Isabella, Author
Giordano, Giulia, Author
Hanson, Claudia, Author
Hel, Zdenek, Author
Hotulainen, Pirta, Author
Klimek, Peter, Author
Nassehi, Armin, Author
Peichl, Andreas, Author
Perc, Matjaz, Author
Petelos, Elena, Author
Prainsack, Barbara, Author
Szczurek, Ewa, Author
Affiliations:
1Max Planck Research Group Neural Systems Theory, Max Planck Institute for Dynamics and Self-Organization, Max Planck Society, ou_2616694              

Content

show
hide
Free keywords: -
 Abstract: COVID-19 cases are very high across
Europe. Current measures are not
reducing virus spread sufficiently,
and new SARS-CoV-2 variants are
emerging. The B.1.1.7 and B1.351
variants, first identified in the UK
and South Africa, respectively,
have spread to many European
countries.1–5 Although the biological
properties of these variants are yet
to be characterised, epidemiological
data suggest they have a higher
transmissibility than the original
variant.6,7 These viral properties could
increase the effective reproduction
number R in the population. In the
case of B.1.1.7, estimates suggest
R could increase from 1 to about
1.4 with no change in population
behavior.3,4 If true, many countries
that have succeeded in reducing R
to 1 or less will be confronted with
a novel wave of viral spread despite
the current measures.8,9
Once a more
contagious variant has established
itself, stabilising the number of new
infections will become increasingly
difficult.

Details

show
hide
Language(s): eng - English
 Dates: 2021-01-212021-06-02
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: DOI: 10.1016/S0140-6736(21)00150-1
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: The Lancet
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: 2 Volume / Issue: 397 Sequence Number: - Start / End Page: 469 - 470 Identifier: ISSN: 01406736